With reference to the earlier letter dated January 28, 2016 informing that a Meeting of the Board of Directors of the Company will be held on February 09, 2016 to consider the Un-Audited Financial Results of the Company for the quarter and nine months ended December 31, 2015. Aurobindo Pharma has now informed that at the Board Meeting to be held on February 09, 2016, the Board will also consider the proposal of payment of Third Interim Dividend for the year 2015-16.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1871.55 |
| Dr. Reddys Labs. | 1346.25 |
| Cipla | 1456.25 |
| Zydus Lifesciences | 1099.65 |
| Lupin | 2398.70 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: